{
    "title": "115_hr5775",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Providing Reliable Options for \nPatients and Educational Resources Act of 2018'' or the ``PROPER Act of \n2018''.\n\nSEC. 2. REQUIRING MEDICARE ADVANTAGE PLANS AND PART D PRESCRIPTION DRUG \n              PLANS TO INCLUDE INFORMATION ON RISKS ASSOCIATED WITH \n              OPIOIDS AND COVERAGE OF NONPHARMACOLOGICAL THERAPIES AND \n              NONOPIOID MEDICATIONS OR DEVICES USED TO TREAT PAIN.\n\n    Section 1860D-4(a)(1) of the Social Security Act (42 U.S.C. 1395w-\n104(a)(1)) is amended--\n            (1) in subparagraph (A), by inserting ``, subject to \n        subparagraph (C),'' before ``including'';\n            (2) in subparagraph (B), by adding at the end the following \n        new clause:\n                            ``(vi) For plan year 2021 and each \n                        subsequent plan year, subject to subparagraph \n                        (C), with respect to the treatment of pain--\n                                    ``(I) the risks associated with \n                                prolonged opioid use; and\n                                    ``(II) coverage of \n                                nonpharmacological therapies, devices, \n                                and nonopioid medications--\n                                            ``(aa) in the case of an \n                                        MA-PD plan under part C, under \n                                        such plan; and\n                                            ``(bb) in the case of a \n                                        prescription drug plan, under \n                                        such plan and under parts A and \n                                        B.''; and\n            (3) by adding at the end the following new subparagraph:\n                    ``(C) Targeted provision of information.--A PDP \n                sponsor of a prescription drug plan may, in lieu of \n                disclosing the information described in subparagraph \n                (B)(vi) to each enrollee under the plan, disclose such \n                information through mail or electronic communications \n                to a subset of enrollees under the plan, such as \n                enrollees who have been prescribed an opioid in the \n                previous 2-year period.''.\n\nSEC. 3. REQUIRING MEDICARE ADVANTAGE PLANS AND PRESCRIPTION DRUG PLANS \n              TO PROVIDE INFORMATION ON THE SAFE DISPOSAL OF \n              PRESCRIPTION DRUGS.\n\n    (a) Medicare Advantage.--Section 1852 of the Social Security Act \n(42 U.S.C. 1395w-22) is amended by adding at the end the following new \nsubsection:\n    ``(n) Provision of Information Relating to the Safe Disposal of \nCertain Prescription Drugs.--\n            ``(1) In general.--In the case of an individual enrolled \n        under an MA or MA-PD plan who is furnished an in-home health \n        risk assessment on or after January 1, 2021, such plan shall \n        ensure that such assessment includes information on the safe \n        disposal of prescription drugs that are controlled substances \n        that meets the criteria established under paragraph (2). Such \n        information shall include information on drug takeback programs \n        that meet such requirements determined appropriate by the \n        Secretary and information on in-home disposal.\n            ``(2) Criteria.--The Secretary shall, through rulemaking, \n        establish criteria the Secretary determines appropriate with \n        respect to information provided to an individual to ensure that \n        such information sufficiently educates such individual on the \n        safe disposal of prescription drugs that are controlled \n        substances.''.\n    (b) Prescription Drug Plans.--Section 1860D-4(c)(2)(B) of the \nSocial Security Act (42 U.S.C. 1395w-104(c)(2)(B)) is amended--\n            (1) by striking ``may include elements that promote'';\n            (2) by redesignating clauses (i) through (iii) as \n        subclauses (I) through (III) and adjusting the margins \n        accordingly;\n            (3) by inserting before subclause (I), as so redesignated, \n        the following new clause:\n                            ``(i) may include elements that promote--\n                        '';\n            (4) in subclause (III), as so redesignated, by striking the \n        period at the end and inserting ``; and''; and\n            (5) by adding at the end the following new clause:\n                            ``(ii) with respect to plan years beginning \n                        on or after January 1, 2021, shall provide \n                        for--\n                                    ``(I) the provision of information \n                                to the enrollee on the safe disposal of \n                                prescription drugs that are controlled \n                                substances that meets the criteria \n                                established under section 1852(n)(2), \n                                including information on drug takeback \n                                programs that meet such requirements \n                                determined appropriate by the Secretary \n                                and information on in-home disposal; \n                                and\n                                    ``(II) cost-effective means by \n                                which an enrollee may so safely dispose \n                                of such drugs.''.\n\nSEC. 4. REVISING MEASURES USED UNDER THE HOSPITAL CONSUMER ASSESSMENT \n              OF HEALTHCARE PROVIDERS AND SYSTEMS SURVEY RELATING TO \n              PAIN MANAGEMENT.\n\n    (a) Restriction on the Use of Pain Questions in HCAHPS.--Section \n1886(b)(3)(B)(viii) of the Social Security Act (42 U.S.C. \n1395ww(b)(3)(B)(viii)) is amended by adding at the end the following \nnew subclause:\n    ``(XII)(aa) With respect to a Hospital Consumer Assessment of \nHealthcare Providers and Systems survey (or a successor survey) \nconducted on or after January 1, 2019, such survey may not include \nquestions about communication by hospital staff with an individual \nabout such individual's pain unless such questions take into account, \nas applicable, whether an individual experiencing pain was informed \nabout risks associated with the use of opioids and about non-opioid \nalternatives for the treatment of pain.\n    ``(bb) The Secretary shall not include on the Hospital Compare \nInternet website any measures based on the questions appearing on the \nHospital Consumer Assessment of Healthcare Providers and Systems survey \nin 2018 about communication by hospital staff with an individual about \nsuch individual's pain.''.\n    (b) Restriction on Use of 2018 Pain Questions in the Hospital \nValue-based Purchasing Program.--Section 1886(o)(2)(B) of the Social \nSecurity Act (42 U.S.C. 1395ww(o)(2)(B)) is amended by adding at the \nend the following new clause:\n                            ``(iii) HCAHPS pain questions.--The \n                        Secretary may not include under subparagraph \n                        (A) a measure that is based on the questions \n                        appearing on the Hospital Consumer Assessment \n                        of Healthcare Providers and Systems survey in \n                        2018 about\n\n\n              \n\n                         communication by hospital staff with an \n                        individual about the individual's pain.''.\n\n            Passed the House of Representatives June 19, 2018.\n\n            Attest:\n\n                                                 KAREN L. HAAS,\n\n                                                                 Clerk."
}